Bio Medica Laboratories Ltd IPO — GMP, Details & Subscription

IPO Details

Open Date

21 May 2026

Close Date

25 May 2026

Allotment

26 May 2026

Listing Date

29 May 2026

Exchange

BSE SME

Price Band

₹139

Listing Price

See chart

Allotment Status

Check Now →

Price Band

₹139

Per share

Face Value

₹10 per share

Lot Size

1,000 Shares

per lot

Issue Size

37,72,000 shares (agg. up to ₹52 Cr)

Total offering

Issue Type

Bookbuilding IPO

Min Investment

₹139,000

1 lot

Pre-IPO Holding

91,80,001 shares

Promoters

Post-IPO Holding

1,25,75,001 shares

Promoters

P/E (Pre)

13.03x

P/E (Post)

13.45x

EPS (Pre)

₹10.67

EPS (Post)

₹10.33

UPI Deadline

5:00 PM on 25 May 2026

Mandate

GMP

+₹2

+1.44% est.

Anchor AllotmentWed, 20 May 2026

Basis of AllotmentTue, 26 May 2026

Refund InitiationWed, 27 May 2026

Demat CreditWed, 27 May 2026

Listing DayFri, 29 May 2026

UPI Mandate Deadline5:00 PM on 25 May 2026

Sale TypeFresh capital cum OFS

Net Offer to Public35,83,000 shares (agg. up to ₹50 Cr)

Market Maker Quota1,89,000 shares (agg. up to ₹3 Cr)

Fresh Issue Shares32,06,000 shares (agg. up to ₹45 Cr)

Offer for Sale3,77,000 shares of ₹10 (agg. up to ₹5 Cr)

QIB Quota50% of Net Issue

HNI / NII Quota15% of Net Issue

Retail Quota35% of Net Issue

Check AllotmentClick here →

Subscription Rate Final

Bio Medica Laboratories Ltd IPO subscribed 2.26 times overall. Retail: 2.92x. QIB: 15.94x. NII: 1.30x. By 25 May 2026.

QIB

15.94x

Over

NII/HNI

1.30x

Over

Retail

2.92x

Over

Total

2.26x

Over

Category	Subscription	Shares Offered	% of Total	Amount (₹Cr)
Market Maker	Awaited	189,000	—	₹2.63
QIB	Over 15.94x	36,000	—	₹0.50
NII / HNI	Over 1.30x	1,755,000	—	₹24.39
Retail	Over 2.92x	1,792,000	—	₹24.91
Total	2.26x	3,583,000	100%	₹49.80

IPO Shares Offered

Bio Medica Laboratories Ltd IPO total issue size: ₹49.80 Cr. Retail: ₹24.91 Cr. QIB: ₹0.50 Cr. NII: ₹24.39 Cr.

Category	Shares Offered	Amount (₹Cr)	Size (%)
QIB	36,000	₹0.50	1.00%
Market Maker	189,000	₹2.63	5.27%
NII	1,755,000	₹24.39	48.98%
Retail	1,792,000	₹24.91	50.01%
Total	3,583,000	₹49.80	100.00%

* Based on upper price band ₹139 per share

Basis of Allotment

	QIB			NII			Retail	Total
	Ex. Anchor	Anchor	Total QIB	Below ₹10L	Above ₹10L	Total NII	Retail	Total
Allocation (shares)	—	—	—	—	—	1,755,000	1,792,000	3,547,000
Allotment price (₹)	139	139	139	139	139	139	139	139
No. of applications	—	—	—	—	—	—	—	—
No. of shares applied	—	—	—	—	—	—	—	—
Amount collected (₹Cr)	—	—	—	—	—	—	₹24.91	₹24.91
Times subscribed	15.94x	—	—	—	—	1.30x	2.92x	2.26x
Shares allotted	—	—	—	—	—	1,755,000	1,792,000	3,547,000
No. of allottees	—	—	—	—	—	—	—	—

* Upper price band ₹139 · ** Anchor allotment excluded from public shares

Lot Size & Investment

Lot Size

1,000

Shares per Lot

Issue Price

₹139.00

Upper Band

Min Investment

₹139,000

1 Lot

Application	Lots	Shares	Amount
Retail (Min — 2 Lots)	2	2,000	₹278,000
Retail (Max — 13 Lots)	13	13,000	₹1,807,000
S-HNI (Min — 14 Lots)	14	14,000	₹1,946,000
B-HNI (Min — 68 Lots)	68	68,000	₹9,452,000

* Issue Price ₹139 × Lot Size 1,000 shares

IPO Schedule

Anchor

20 May 2026

✓ Done

IPO Open

21 May 2026

✓ Done

IPO Close

25 May 2026

✓ Done

Allotment

26 May 2026

✓ Done

Refunds

27 May 2026

✓ Done

Demat Credit

27 May 2026

✓ Done

Listing Day

29 May 2026

✓ Done

₹139.00

INR · BSE

Fetching…

vs Issue Price

—

OPEN

—

HIGH

—

LOW

—

MKT CAP

—

P/E

—

52W HIGH

—

52W LOW

—

VOLUME

—

DIVIDEND

—

DIV YIELD

—

Loading…

Chart Not Available

Try again 2–3 days after listing.

Issue ₹139.00 GMP: +₹2 Live Price

About Bio Medica Laboratories Ltd

Incorporated in August 2015, Bio Medica Laboratories specialises in manufacturing pharmaceutical parenteral formulations, producing a wide range of ethical drugs, generic drugs, and over-the-counter (OTC) medications in liquid and dry-powder injectable forms.der injectables. These injectables are available in both single-dose and multi-dose formats, serving the needs of both human and veterinary healthcare.Product portfolio:Liquid Injectables: 58 products are offered under this categoryDry powder injectables: 15 products under this categoryIt offers comprehensive range of products, including generic drugs, branded pharmaceuticals, over the counter (OTC) products, and other medications.The company operates on a B2B model, focusing exclusively on contract manufacturing. It develop formulations for various companies in accordance with their specific requirements and product specifications. It is certified for Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP) certificate issued by the Food & Drugs Administration, Madhya Pradesh.It has two manufacturing facilities in Indore, Madhya Pradesh.Competitive StrengthsMulti-product capability and diversified product portfolioExperienced promoters, management and employees.Quality assuranceEstablished client relationship

Objects of the Issue

Repayment of loan

Enhancement of its existing production capabilities by setting up of new manufacturing facility at the existing premises

General Corporate Purposes

Bio Medica Laboratories Ltd Financials (Amount in ₹ Crore)

Revenue from Operations

₹15.3

31 Mar 2024

₹38.3

31 Mar 2025

₹28.6

30 Nov 2025

Profit After Tax (PAT)

₹2.5

31 Mar 2024

₹9.8

31 Mar 2025

₹8.7

30 Nov 2025

Particulars	30 Nov 2025	31 Mar 2025	31 Mar 2024
Revenue from Operations	28.63	38.33	15.34
EBITDA	13.45	15.21	5.63
Profit After Tax (PAT)	8.66	9.79	2.50
Net Worth	17.12	14.73	4.94
Total Assets	65.17	39.12	19.53
Reserves & Surplus	7.94	5.55	4.84
Borrowings	38.17	15.01	10.49
EBITDA Margin (%)	47.11	—	—
PAT Margin (%)	30.35	—	—

RoE

54.41

RoCE

23.22

RoNW

54.41

PAT Margin

30.35

EBITDA Margin

47.11

Debt/Equity

2.23

Issue Structure & Shareholding

Total Shares Offered37,72,000

Net Offer to Public35,83,000 shares (agg. up to ₹50 Cr)

Reserved for Market Maker1,89,000 shares (agg. up to ₹3 Cr)

Pre-Issue Promoter Holding91,80,001 shares

Post-Issue Promoter Holding1,25,75,001 shares

P/BV RatioN/A

RoE54.41

RoCE23.22

Debt / Equity2.23

Script CodeN/A

Registrar & Lead Managers

IPO Registrar

Skyline Financial Services Pvt.Ltd

02228511022

ipo@skylinerta.com

https://www.skylinerta.com/ipo.php

Check Allotment

Book Running Lead Managers

Narnolia Financial Services Ltd

GMP Disclaimer: Grey Market Premium data is unofficial and unregulated. It does not guarantee actual listing price.

IPO Subscription FAQs

How much Bio Medica Laboratories Ltd IPO subscribed? ▲

Bio Medica Laboratories Ltd IPO is subscribed 2.26 times by May 25, 2026. Retail: 2.92x. QIB: 15.94x. NII: 1.30x.

Investor Category	Subscription
Qualified Institutional (QIB)	15.94x
Non Institutional (NII/HNI)	1.30x
Retail Individual	2.92x
Total Subscription	2.26x

What is Bio Medica Laboratories Ltd IPO retail subscription status? ▼

The Bio Medica Laboratories Ltd IPO retail category is subscribed 2.92 times as of 25 May 2026. The retail portion is oversubscribed.

How to subscribe Bio Medica Laboratories Ltd IPO? ▼

Subscribe via your broker app using ASBA or UPI. Opens 21 May 2026 and closes 25 May 2026. Min investment: ₹139,000 (1 lot = 1,000 shares). UPI mandate: 5:00 PM on 25 May 2026.

How many times Bio Medica Laboratories Ltd IPO subscribed? ▼

The Bio Medica Laboratories Ltd IPO subscribed 2.26x overall. QIB: 15.94x, NII: 1.30x, Retail: 2.92x. Applications: from NSE/BSE.

How to check Bio Medica Laboratories Ltd IPO allotment? ▼

Check allotment on the registrar website (Skyline Financial Services Pvt.Ltd) at https://www.skylinerta.com/ipo.php. Enter your PAN, application number or DP/Client ID. Allotment date: 26 May 2026. Refunds: on 27 May 2026.

When Bio Medica Laboratories Ltd IPO will be listed? ▼

The Bio Medica Laboratories Ltd IPO listing date is 29 May 2026, Friday. Listed on: BSE SME. Issue price: ₹139. Estimated listing: ₹141. GMP: +₹2.

When Bio Medica Laboratories Ltd IPO close? ▼

The Bio Medica Laboratories Ltd IPO closes on 25 May 2026, Monday. UPI mandate: 5:00 PM on 25 May 2026. Allotment: 26 May 2026. Listing: 29 May 2026.

Quick Actions

Check Allotment

Live Price LIVE

Last Price₹139.00

Change—

Issue Price₹139.00

vs Issue—

Quick Summary

StatusListed

Issue Price₹139

Face Value₹10

Lot Size1,000 Sh

Min. Amount₹139,000

GMP+₹2

Est. Listing₹141

Subscribed2.26x

Open Date21 May 2026

Close Date25 May 2026

Allotment26 May 2026

Listing Date29 May 2026

ExchangeBSE SME

UPI Deadline5:00 PM on 25 May 2026